Amarin Corp Plc (AMRN)

[ziploc_1]

Jas...QUOTE...Vascepa is actually cost-effective. If every patient that qualifies for Vascepa starts using it, it will save millions of lives and save the healthcare system millions of dollars. What’s the problem??"

IMO insurance companies don't much care about drugs that help their patients in the future ,i.e. after taking these drugs for a period of three to five years...because many of these same patients will have switched their policies to other insurers during that time...and these other NEW insurance companies will accrue the benefits of less cash outlay for less future hospitalizations for these patients that the OLD insurance companies will have subsidized out of their current cash .

Insurance companies advertise that their main interest is in the health of their patients...but their actual main interest is in their bottom line.

We can expect the patients and their families and their Docs to care , but it is naive to expect insurance companies to care.